Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Cervical Cancer

  Free Subscription


26.10.2026

1 Am J Clin Pathol
1 Aust J Prim Health
1 Balkan Med J
1 Behav Med
1 Biochimie
3 BMC Cancer
1 BMC Complement Med Ther
1 BMC Health Serv Res
1 BMC Public Health
2 BMC Womens Health
2 BMJ Open
1 Br J Cancer
1 Cancer Control
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Med
1 Cancer Nurs
1 Cell Mol Life Sci
1 Chem Biodivers
1 Clin Exp Metastasis
1 Clin Transl Oncol
1 Cureus
1 Curr Cancer Drug Targets
1 Environ Health (Wash)
1 ESMO Open
2 Eur J Cancer
1 Eur J Pharm Sci
1 FASEB J
1 Front Cell Infect Microbiol
1 Front Genet
2 Front Immunol
2 Front Oncol
2 Front Pharmacol
1 Front Public Health
1 Gates Open Res
1 Gynecol Oncol
1 Infect Agent Cancer
2 Int J Cancer
1 Int J Infect Dis
1 Int J Womens Health
1 J Clin Ultrasound
1 J Health Psychol
1 J Med Chem
1 J Med Imaging Radiat Oncol
1 J Med Phys
1 J Med Virol
1 J Vis Exp
1 J Womens Health (Larchmt)
1 JAMA Netw Open
1 Jpn J Radiol
1 Magn Reson Imaging
1 Mater Today Bio
1 Mayo Clin Proc Digit Health
1 Med Oncol
1 Medicine (Baltimore)
1 Mol Biol Rep
1 Mol Genet Genomic Med
1 Nat Prod Bioprospect
1 Neoplasia
1 Oncogene
1 Physiother Res Int
1 PLoS One
1 Prev Med Rep
1 Radiography (Lond)
1 Ther Clin Risk Manag


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Clin Pathol

  1. CORBIN H, Matsko J, Charity T, Colaizzi A, et al
    Interobserver variability in the interpretation of Papanicolaou tests using the Hologic Genius Digital Diagnostics System: detailed analysis of cytology verification in a large academic laboratory.
    Am J Clin Pathol. 2026;166:aqag113.
    PubMed         Abstract available


    Aust J Prim Health

  2. ABBAS S, Teague K, Brotherton J, Stelmach W, et al
    Health system responsiveness in cervical screening: experiences of Muslim immigrant women in Australia.
    Aust J Prim Health. 2026;32:PY26151.
    PubMed         Abstract available


    Balkan Med J

  3. ZHANG Y, Shen G, Luo L, Feng Y, et al
    HPV16 E7-Containing Exosomes May Contribute to PD-L1 Expression in Tumor-Infiltrating Lymphocytes of Cervical Cancer.
    Balkan Med J. 2026 Oct 19. doi: 10.4274/balkanmedj.galenos.2026.2026.
    PubMed         Abstract available


    Behav Med

  4. TSUI J, Wurtz H, Rockson A, Dang E, et al
    Healthcare Inequities and Structural Racism as Determinants of Treatment and Survival among Individuals Recently Diagnosed with Cervical Cancer from Two Diverse Population-Based Cancer Registries: The ACHIEVE Study.
    Behav Med. 2026;52.
    PubMed         Abstract available


    Biochimie

  5. GALEGO GB, Holanda LF, Willig JB, Santos LTD, et al
    Divergent Effects of Trichomonas vaginalis on Cervical Cancer Cells HPV-positive and HPV-negative: Interplay with Purinergic Signaling.
    Biochimie. 2026 Oct 20:S0300-9084(26)00267-1. doi: 10.1016/j.biochi.2026.
    PubMed         Abstract available


    BMC Cancer

  6. XU J, Chen J, Zhu L, Wang M, et al
    The efficacy and safety of neoadjuvant chemotherapy plus immune check point inhibitors for locally advanced cervical cancer: a systematic review and meta-analysis.
    BMC Cancer. 2026;26:1246.
    PubMed         Abstract available

  7. QI X, Xiang Z, Wang W, Liu K, et al
    Re-irradiation with image-guided radiotherapy for recurrent cervical cancer: an analysis of outcomes and toxicity.
    BMC Cancer. 2026;26:1261.
    PubMed         Abstract available

  8. MUZI CD, Veggi AB, Coutinho RPM, Albuquerque DBS, et al
    Regional divergence in female cancer mortality in Brazil signals the unequal pace of the cancer transition.
    BMC Cancer. 2026;26:1279.
    PubMed         Abstract available


    BMC Complement Med Ther

  9. PINA-CRUZ R, Molina-Pineda A, Vizcarra-Ramos S, Garcia-Gomez J, et al
    Integrated transcriptomic and functional analysis reveals selective cytotoxicity and HPV oncogene suppression induced by cinnamon essential oil in cervical cancer cells.
    BMC Complement Med Ther. 2026;26:316.
    PubMed         Abstract available


    BMC Health Serv Res

  10. SHIMELS T, Gashawbeza B, Fenta TG
    The economic burden of cervical cancer in Addis Ababa: a matched case-control study.
    BMC Health Serv Res. 2026;26:1446.
    PubMed         Abstract available


    BMC Public Health

  11. ONCU E, Korun ZEU, Yazici MGK, Yesiladali M, et al
    High intention, low uptake: HPV vaccination knowledge, attitudes, and behavior among women attending a tertiary gynecology clinic in Turkey.
    BMC Public Health. 2026;26:3013.
    PubMed         Abstract available


    BMC Womens Health

  12. SHABAN MM, Mohamed NA, Shaban M
    "Barriers beneath the surface": healthcare access and cultural beliefs affecting cervical cancer screening among egyptian women: a qualitative study.
    BMC Womens Health. 2026;26:531.
    PubMed         Abstract available

  13. GE Y, Chen Z, Zhu Y, Xu H, et al
    Risk factors for recurrent disease after loop electrosurgical excision procedure in patients with cervical intraepithelial neoplasia: a systematic review and meta-analysis.
    BMC Womens Health. 2026;26:541.
    PubMed         Abstract available


    BMJ Open

  14. FRIDLJUNG J, Bergengren L, Lillsunde-Larsson G, Ryen L, et al
    Clinical yield and operational cost-threshold analysis of HPV self-sampling send-outs for long-term non-attenders in cervical cancer screening: a population-based, real-world, registry study in Sweden.
    BMJ Open. 2026;16:e125034.
    PubMed        

  15. VEERAVAGU T, Hamdiui N, Stein ML, Al-Rubaie NHS, et al
    Stakeholders' perspectives on communication gaps in cervical cancer prevention among women of Turkish, Moroccan and Syrian origin: a focus group study in the Netherlands.
    BMJ Open. 2026;16:e120419.
    PubMed         Abstract available


    Br J Cancer

  16. MEJIA GUARNIZO LV, Trujillo Gama CE, Lopez Kleine L, Orozco Castano CA, et al
    Identification of microRNAs as biomarkers for triage of cervical intraepithelial neoplasia in cervical scrape samples from high-risk HPV-positive women.
    Br J Cancer. 2026 Aug 4. doi: 10.1038/s41416-026-03521.
    PubMed         Abstract available


    Cancer Control

  17. ATSBAHA AH, Amare HH, Geta TG, Belay S, et al
    Burden and Trends of Cervical Cancer in Ethiopia, from 1990 to 2023.
    Cancer Control. 2026;33:10732748261500282.
    PubMed         Abstract available


    Cancer Epidemiol Biomarkers Prev

  18. SINGHAL S, Tanwar P, Jayraj AS, Jamali SN, et al
    Clinical Performance and User-Informed Refinement of an Indigenous HPV Self-Collection Device for Cervical Cancer Screening in Resource-Constrained Settings.
    Cancer Epidemiol Biomarkers Prev. 2026.
    PubMed         Abstract available


    Cancer Med

  19. PANG X, Qin X, Que L, Li W, et al
    CBX4 and NOX4 Expression Are Associated With Chemoradiotherapy Response and Overall Survival in Locally Advanced Cervical Squamous Cell Carcinoma.
    Cancer Med. 2026;15:e72402.
    PubMed         Abstract available


    Cancer Nurs

  20. PARKER L, Freire K, Kwok C
    Nurse Colposcopy: A Scoping Review.
    Cancer Nurs. 2026;49:e889-e895.
    PubMed         Abstract available


    Cell Mol Life Sci

  21. ZHOU Y, Ge Y, Liu K, Liu H, et al
    From HPV infection to cervical precancer: Molecular mechanisms, immune microenvironment and emerging technologies.
    Cell Mol Life Sci. 2026;83:383.
    PubMed         Abstract available


    Chem Biodivers

  22. PAN X, Liu D, Chen J, Deng H, et al
    Molecular Targets and Potential Mechanisms of Luteolin Against Cervical Carcinoma: Integrative Approach Combining Network Pharmacology, Molecular Docking, Molecular Dynamics Simulations, and In Vitro Validation.
    Chem Biodivers. 2026;23:e71860.
    PubMed         Abstract available


    Clin Exp Metastasis

  23. WANG QX, Chen LY, Wu SG, Zhou J, et al
    Brachytherapy-based local radiotherapy improves survival in newly diagnosed metastatic cervical cancer.
    Clin Exp Metastasis. 2026;43:57.
    PubMed         Abstract available


    Clin Transl Oncol

  24. MARTINEZ AG, Gonzalez-Martin A, de Agustin LC
    HPV-related cancer prevention in Spain: progress and remaining challenges in vaccination, screening, and surveillance.
    Clin Transl Oncol. 2026;28:5143-5153.
    PubMed         Abstract available


    Cureus

  25. YADAV KK, Prasad GRV, Rai B, Sharma A, et al
    Prevalence of Deep Vein Thrombosis in Patients With Cervical Cancer.
    Cureus. 2026;18:e116617.
    PubMed         Abstract available


    Curr Cancer Drug Targets

  26. XIE F, Zhu Q, Yang S, Jin X, et al
    CDK8 as a Therapeutic Target for Overall Survival Prediction in Cervical Squamous Cell Carcinoma (CESC).
    Curr Cancer Drug Targets. 2026;26:884-896.
    PubMed         Abstract available


    Environ Health (Wash)

  27. LIN Y, Qiu J, Jiang L, Li S, et al
    Long-Term Exposure to Ambient Air Pollution and Cervical Cancer Outcomes in Chinese Women: A Prospective Study on Recurrence and Mortality Risks.
    Environ Health (Wash). 2026;4:2278-2288.
    PubMed         Abstract available


    ESMO Open

  28. LORUSSO D, Cibula D, Colombo I, Felix A, et al
    Cervical cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
    ESMO Open. 2026;11:108364.
    PubMed        


    Eur J Cancer

  29. WIDSCHWENDTER M, Dillner J, Sundstrom K, Wang J, et al
    Letter Re: Diagnostic testing accuracy of DNA methylation tests for detection of high-grade cervical intraepithelial neoplasia and cervical cancer: A systematic review and meta-analysis.
    Eur J Cancer. 2026;249:117777.
    PubMed        

  30. STEENBERGEN RDM, Heideman DAM, Wisman GBA, Nedjai B, et al
    Letter re: "diagnostic testing accuracy of DNA methylation tests for detection of high-grade cervical intraepithelial neoplasia and cervical cancer: a systematic review and meta-analysis".
    Eur J Cancer. 2026;248:117778.
    PubMed        


    Eur J Pharm Sci

  31. SZITA DB, Beres E, Szabo JP, Dienes RA, et al
    Radiolabelled cyclodextrins to detect cervical cancer: a preclinical feasibility study.
    Eur J Pharm Sci. 2026;227:107692.
    PubMed         Abstract available


    FASEB J

  32. MUKHERJEE S, Chakraborty S, Basak U, Banik SK, et al
    Modulation of beta-Catenin/EMT Axis by Croton caudatus and Its Phytoflavonoid Kaempferol Ameliorates Cervical Cancer Migration and Stemness.
    FASEB J. 2026;40:e72377.
    PubMed         Abstract available


    Front Cell Infect Microbiol

  33. LIU Y, Ma C, Quan L, Li Y, et al
    Vaginal microbiota and functional prediction along the progression of cervical lesions in postmenopausal women.
    Front Cell Infect Microbiol. 2026;16:1911664.
    PubMed         Abstract available


    Front Genet

  34. ZHANG H, Zhu Y, Shao W, Xu K, et al
    Interpretable machine learning prioritizes transcriptomic features associated with ferroptosis-mitochondrial permeability transition net activity states in cervical cancer.
    Front Genet. 2026;17:1930345.
    PubMed         Abstract available


    Front Immunol

  35. LI J, Deng Y, Wu T, Xu C, et al
    Anti-PD-1/CTLA-4 bispecific antibody-based combination therapy for cervical cancer: a multicenter study with biomarker analysis.
    Front Immunol. 2026;17:1967065.
    PubMed         Abstract available

  36. SHAN B, Yang R, Peng Y, Li M, et al
    Case Report: Severe multi-organ damage induced by cadonilimab: mechanism investigation and management strategies.
    Front Immunol. 2026;17:1961670.
    PubMed         Abstract available


    Front Oncol

  37. MAKGOO L, Mbita Z
    Chemoresistance in cervical cancer: identifying and exploiting non-coding RNAs.
    Front Oncol. 2026;16:1913768.
    PubMed         Abstract available

  38. ZHANG Q, Li L, Li X, Zou D, et al
    Laparoscopic para-aortic and pelvic lymphadenectomy before chemoradiotherapy was not associated with improved survival in patients with FIGO stage IIB-IIIC cervical cancer: a single-center retrospective study.
    Front Oncol. 2026;16:1975884.
    PubMed         Abstract available


    Front Pharmacol

  39. ZHANG Q, Wang X, Chen Y, Feng H, et al
    Durable complete response to tislelizumab in advanced pMMR cervical cancer and successful rechallenge after immune-related NSTEMI: a case report.
    Front Pharmacol. 2026;17:1947402.
    PubMed         Abstract available

  40. MAI Y, Ju K, Yang Y, Wang W, et al
    Quercetin upregulates TLE4 to block the Wnt/beta-catenin signaling pathway and inhibit cell migration and invasion of cervical cancer cells.
    Front Pharmacol. 2026;17:1892382.
    PubMed         Abstract available


    Front Public Health

  41. XIE M, Zhao M
    Health information literacy mediates the relationship between active information seeking and HPV-related knowledge among female undergraduates: the moderating role of information channel characteristics.
    Front Public Health. 2026;14:1947194.
    PubMed         Abstract available


    Gates Open Res

  42. OMBALLA V, Luchetta J, Amaru R, Joshi V, et al
    Analytical performance and clinical usability of a low-cost vaginal swab for sensitive detection of high-risk human papillomavirus.
    Gates Open Res. 2026;10:69.
    PubMed         Abstract available


    Gynecol Oncol

  43. COQUAN E, Vion R, Colomba-Blamemble E, Frenel JS, et al
    Phase II study of cabozantinib in recurrent or metastatic cervical cancer after progression on platinum-based chemotherapy (CABOCOL).
    Gynecol Oncol. 2026;214:164-172.
    PubMed         Abstract available


    Infect Agent Cancer

  44. ATIBIOKE OP, Ojomo OA, Oyasope BT, Olubiyi BF, et al
    Knowledge of cervical cancer and uptake of HPV vaccine among in-school adolescent girls in Kwara State, Nigeria.
    Infect Agent Cancer. 2026;21:70.
    PubMed         Abstract available


    Int J Cancer

  45. DEBEAUDRAP P, Kabore FN, Setha L, Tegbe J, et al
    Follow-Up and Outcomes After Thermal Ablation Treatment Among HIV-Infected Women From Resource-Limited Countries With Positive HPV-Based Screening: Results of the AIMA-CC Cohort (ANRS 12375).
    Int J Cancer. 2026 Jul 15. doi: 10.1002/ijc.70648.
    PubMed         Abstract available

  46. CARVAJAL LJ, Shing JZ, Vanegas JC, Ocampo R, et al
    Trends in Incidence Rates of Anogenital Cancers in Costa Rica, 1996-2022.
    Int J Cancer. 2026;159:2940-2950.
    PubMed         Abstract available


    Int J Infect Dis

  47. ZHOU Y, Lei W, Yang Y, Li Z, et al
    Chlamydia trachomatis co-infection and cervical cancer risk in HPV-positive women: a cross-sectional and histological case-control study.
    Int J Infect Dis. 2026 Oct 17:109190. doi: 10.1016/j.ijid.2026.109190.
    PubMed         Abstract available


    Int J Womens Health

  48. LAKSHMANASAMY R, Palaniraja S, Suriyamoorthy A, Oommen AM, et al
    Cervical Cancer Elimination in India: Progress, Gaps, and the Priorities.
    Int J Womens Health. 2026;18:635866.
    PubMed         Abstract available


    J Clin Ultrasound

  49. XIA Z, Huang X, Miao Q, Wang H, et al
    Multimodal Ultrasound for Early Prognostic Assessment During Definitive Radiotherapy in Locally Advanced Cervical Cancer.
    J Clin Ultrasound. 2026 Oct 21. doi: 10.1002/jcu.70449.
    PubMed         Abstract available


    J Health Psychol

  50. CULLUM C, Mason C, Meyrick J
    Increasing Uptake Of Screening For Women's Cancers: A Systematic Review Of Interventions To Increase Attendance At First Invitation.
    J Health Psychol. 2026;31:5221-5238.
    PubMed         Abstract available


    J Med Chem

  51. NI D, Wang T, Yang J, Wang L, et al
    Discovery of Diaryl Pyrimidine-Guanidine Derivatives as Jumonji C Domain-Containing Lysine Histone Demethylase (KDM) Inhibitors with In Vivo Anti-Cervical Cancer Activity.
    J Med Chem. 2026;69:24472-24495.
    PubMed         Abstract available


    J Med Imaging Radiat Oncol

  52. KU D, Wei W, Rutherford N
    Prognosticating Factors in PET CT and MRI of Cervical Cancer Treated With Chemoradiotherapy.
    J Med Imaging Radiat Oncol. 2026 Oct 21. doi: 10.1111/1754-9485.70210.
    PubMed         Abstract available


    J Med Phys

  53. SHARMA PK, Gupta SK, Gupta D
    In vivo Dose Measurement in Cervical Cancer Brachytherapy Using Dysprosium-doped Calcium Sulfate Thermoluminescent Dosimeters: A Phantom Study.
    J Med Phys. 2026;51:653-661.
    PubMed         Abstract available


    J Med Virol

  54. CHEN J, Xie Z, Liu X, Zheng L, et al
    Integrating scRNA-Seq and Spatial Transcriptomics Reveal Novel Risk Stratification Signatures in Cervical Carcinoma.
    J Med Virol. 2026;98:e71184.
    PubMed         Abstract available


    J Vis Exp

  55. MURALIDHARAN P, Sankar V, Sivadasan D
    ABCB1-Mediated Olaparib Resistance in Cervical Cancer: Molecular Mechanisms and Therapeutic Strategies.
    J Vis Exp. 2026;.
    PubMed         Abstract available


    J Womens Health (Larchmt)

  56. MORITZ RE, Whitney E, Fink D, Ehlers S, et al
    Estimating the Annual Proportion of U.S. Women Receiving Cervical Cancer Screening Tests by Age Group and Race and Ethnicity, 2008-2023.
    J Womens Health (Larchmt). 2026 Oct 17:15409996261497771.
    PubMed         Abstract available


    JAMA Netw Open

  57. HAURY J, Chanier JB, Renevier B, Canlorbe G, et al
    Multiple Dimensions of Social Vulnerability and Cervical Cancer Screening Uptake.
    JAMA Netw Open. 2026;9:e2639570.
    PubMed         Abstract available


    Jpn J Radiol

  58. EJIMA F, Yamagishi R, Oose A, Kanzaki F, et al
    MRI-defined parametrial venous invasion in locally advanced cervical cancer: association with pathological venous invasion, pretreatment lymph node metastasis, and survival outcomes.
    Jpn J Radiol. 2026 Oct 17. doi: 10.1007/s11604-026-02099.
    PubMed         Abstract available


    Magn Reson Imaging

  59. YANG C, Wu M, Tan C, Qiao Y, et al
    Multiparametric MRI with amide proton transfer imaging for assessing stromal invasion depth of early- stage cervical cancer.
    Magn Reson Imaging. 2026 Oct 17:110814. doi: 10.1016/j.mri.2026.110814.
    PubMed         Abstract available


    Mater Today Bio

  60. YANG Z, Zhang L, Wang Z, Hu C, et al
    Tumor microenvironment-responsive manganese nanocarriers for on-demand release of methotrexate and DNAzyme in MiR-155-driven cervical cancer.
    Mater Today Bio. 2026;41:103747.
    PubMed         Abstract available


    Mayo Clin Proc Digit Health

  61. FAI KGN, Conrad TS, Galega LB, Mbu TF, et al
    A Patient-Centered Digitally Enabled Smart Speculum for Cervical Cancer Screening in Cameroon: A Paired Comparative Clinical Study.
    Mayo Clin Proc Digit Health. 2026;4:100402.
    PubMed         Abstract available


    Med Oncol

  62. SRISUPHAN R, Rayanil KO, Pengnam S, Wongprayoon P, et al
    The neolignan Miliusin B inhibits cell migration and promotes apoptotic cell death in cervical cancer cell line HeLa.
    Med Oncol. 2026;43:347.
    PubMed         Abstract available


    Medicine (Baltimore)

  63. TAN C, Dai H, Liu X, Xu N, et al
    Impact of the COVID-19 pandemic on diagnosis, treatment, and prognosis of cervical, endometrial, and ovarian cancers: A retrospective cohort study based on the SEER database.
    Medicine (Baltimore). 2026;105:e51038.
    PubMed         Abstract available


    Mol Biol Rep

  64. ROOZBEHANI M, Vafaei S, Keyvani H, Faraji F, et al
    Modulation of the NAMPT/SIRT axis in HeLa cells exposed to adipose-derived mesenchymal stem cell-conditioned medium.
    Mol Biol Rep. 2026;53:1780.
    PubMed         Abstract available


    Mol Genet Genomic Med

  65. DIAN AL, Cunha APA, Melo CPS, Nascimento MDDSB, et al
    Prognostic Impact of ERAP1 Genetic Variants and Haplotypes in Cervical Cancer: Insights From TCGA-CESC and a Brazilian Patient Cohort.
    Mol Genet Genomic Med. 2026;14:e70170.
    PubMed         Abstract available


    Nat Prod Bioprospect

  66. WANG X, Zhu C, Du X, Wang Q, et al
    Bioactive components from Sinomenium acutum exhibit anti-inflammatory activity and sensitize cervical cancer cells to paclitaxel.
    Nat Prod Bioprospect. 2026;16:94.
    PubMed         Abstract available


    Neoplasia

  67. ZHANG Y, Zhu L, Xia L, Cheng H, et al
    Ubiquitin-specific proteases and the immune microenvironment in cervical cancer: mechanistic evidence, immunotherapy resistance, and therapeutic perspectives.
    Neoplasia. 2026;82:101378.
    PubMed         Abstract available


    Oncogene

  68. ZHU C, Wei Y, Li Y, Chen Z, et al
    Circular RNA MCM3 recruits USP49 to stabilize PTBP1 and promote cisplatin resistance in cervical squamous cell carcinoma.
    Oncogene. 2026;45:4630-4646.
    PubMed         Abstract available


    Physiother Res Int

  69. ZHU L, Zhou C, Tong Y, Zhou Y, et al
    Epidemiological Trends and Global Burden of Cervical Cancer: Insights From the 2021 Global Burden of Disease Study.
    Physiother Res Int. 2026;31:e70362.
    PubMed         Abstract available


    PLoS One

  70. ALEMU GG, Bazezew AM, Yirsaw AN, Wondie WT, et al
    Precancerous cervical lesions and associated factors among HIV-positive women in Southern and Eastern African countries: A systematic review and meta-analysis.
    PLoS One. 2026;21:e0361185.
    PubMed         Abstract available


    Prev Med Rep

  71. SOUSA R, Fonseca-Moutinho JA, Gomes F, Loureiro F, et al
    Healthcare professionals' communication practices and preparedness in organised human papillomavirus-based cervical Cancer screening: A cross-sectional study in Central Portugal.
    Prev Med Rep. 2026;71:103666.
    PubMed         Abstract available


    Radiography (Lond)

  72. BEN REJEB M, Lahiouel S, Hamdoun A, Abdessatar G, et al
    CBCT-guided plan-of-the-day adaptive radiotherapy for locally advanced cervical cancer: Feasibility and dosimetric evaluation in a resource-limited setting.
    Radiography (Lond). 2026;32:103606.
    PubMed         Abstract available


    Ther Clin Risk Manag

  73. LENG J, Wei W, Wen X, Lu S, et al
    Knowledge Graphs for Cervical Cancer Across the Care Continuum: From Vaccination and Screening to Personalized Therapy.
    Ther Clin Risk Manag. 2026;22:619879.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum